Skip to content
value.today

IRulya Therapeutics Inc.: insider trading

197 trades by 24 directors, officers and 10% owners since 2019, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$174 K
1 sale by 1 insider
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$163 K-$174 K$0Nov 2023: bought $27 K (2 trades), sold $0 (0 trades)Nov 23Dec 2023: bought $141 K (8 trades), sold $0 (0 trades)DecAug 2024: bought $163 K (9 trades), sold $0 (0 trades)AugDec 2025: bought $0 (0 trades), sold $174 K (1 trades)Dec
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (24)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

IRulya Therapeutics Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
John MilitelloChief Financial Officer80,000——
Luca BenattiDirector39,179—$174 K
Dirk ThyeCEO and CMO, Director255,000——
Brendan HannahCBO, COO & CCO361,827——
Charles S. RyanPresident130,009——
David LamondDirector2.30 M——
Margaret McLoughlinDirector8,000——
Ted MonohonChief Accounting Officer & VP27,440——
Caryn Gordon McDowellChief Legal & Adm. Officer122,500——
Leslie HolsingerEVP, Preclinical Development148,080——
Karen L. SmithChief Medical Officer194,690——
Philip S. LowDirector455,309——
Christopher P. LoweInterim CEO, COO & CFO265,000——
Michael J. DetkeChief Medical Officer140,000——
Casey LynchChief Executive Officer, Director109,895——
Stephen S. DominyChief Scientific Officer, Director———
Chad BoedingManaging Member of Managing Me2.84 M——
Pfizer Strategic Investment Holdings LLC10% owner2.88 M——
EPIQ Capital Group, LLCIA/Managing Member of 10% owne2.85 M——
Christine Lamond10% owner———
Kevin YoungDirector30,000——
Pfizer Ventures (US) LLC10% owner3.25 M——
Takeda Pharmaceutical Co LTD10% owner2.68 M——
Una S. RyanDirector———

Trades#

IRulya Therapeutics Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Dirk ThyeCEO AND CHIEF MEDICAL OFFICER, DirectorBuy+77,000$0.700$54 K843,941Form 4
filed Dirk ThyeCEO AND CHIEF MEDICAL OFFICER, DirectorBuy+77,500$0.690$53 K766,941Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+2,280$0.610$1 K267,975Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+5,000$0.620$3 K272,975Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+23,565$0.630$15 K296,540Form 4
filed Charles S. RyanPRESIDENTBuy+48,387$0.650$31 K122,461Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+2,500$0.610$2 K262,271Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+3,424$0.600$2 K265,695Form 4
filed Brendan HannahCHIEF BUSINESS OFFICER AND COOBuy+2,155$0.580$1 K259,771Form 4
filed David LamondDirectorBuyindirect+22,627$1.040$24 K2.35 MForm 4
filed David LamondDirectorBuyindirect+22,627$1.000$23 K2.32 MForm 4
filed David LamondDirectorBuyindirect+300$1.000$3002.28 MForm 4
filed David LamondDirectorBuy+22,327$1.020$23 K2.30 MForm 4
filed David LamondDirectorBuyindirect+19,123$1.010$19 K2.28 MForm 4
filed David LamondDirectorBuyindirect+19,123$1.020$20 K2.26 MForm 4
filed David LamondDirectorBuyindirect+19,123$1.010$19 K2.24 MForm 4
filed David LamondDirectorBuyindirect+14,378$0.940$14 K2.22 MForm 4
filed David LamondDirectorBuyindirect+14,378$0.900$13 K2.21 MForm 4
filed David LamondDirectorBuyindirect+14,378$0.980$14 K2.19 MForm 4
filed David LamondDirectorBuyindirect+41,026$1.320$54 K2.18 MForm 4
filed David LamondDirectorBuyindirect+41,026$1.310$54 K2.14 MForm 4
filed David LamondDirectorBuyindirect+24,766$1.290$32 K2.10 MForm 4
filed David LamondDirectorBuyindirect+117,348$1.290$151 K2.07 MForm 4
filed David LamondDirectorBuyindirect+107,886$1.320$142 K1.95 MForm 4
filed Dirk ThyeChief Executive Officer, DirectorBuy+88,000$1.260$111 K448,911Form 4
filed Dirk ThyeChief Executive Officer, DirectorBuy+80,000$1.240$99 K360,911Form 4
filed Margaret McLoughlinDirectorBuy+8,000$1.230$10 K8,000Form 4
filed Brendan HannahChief Business OfficerBuy+71,762$1.220$88 K201,555Form 4
filed Stephen S. DominyChief Scientific Officer, DirectorBuyindirect+763$14.40$11 K1.22 MForm 4
filed David LamondDirectorBuyindirect+50,000$33.77$1.7 M1.85 MForm 4
filed David LamondDirectorBuyindirect+16,621$34.28$570 K1.76 MForm 4
filed David LamondDirectorBuyindirect+13,310$35.00$466 K1.78 MForm 4
filed David LamondDirectorBuyindirect+15,969$36.34$580 K1.79 MForm 4
filed David LamondDirectorBuyindirect+4,100$36.86$151 K1.80 MForm 4
filed Chad BoedingManaging Member of Managing MeBuyindirect+2,440$44.06$108 K2.86 MForm 4
filed Chad BoedingManaging Member of Managing MeBuyindirect+6,600$44.32$293 K2.86 MForm 4
filed David LamondDirectorBuyindirect+13,609$42.13$573 K1.71 MForm 4
filed David LamondDirectorBuyindirect+10,642$43.32$461 K1.72 MForm 4
filed David LamondDirectorBuyindirect+24,874$43.88$1.1 M1.75 MForm 4
filed Chad BoedingManaging Member of 10% OwnerBuyindirect+2,085$55.90$117 K2.85 MForm 4
filed Chad BoedingManaging Member of 10% OwnerBuyindirect+520$55.80$29 K2.85 MForm 4
filed Chad BoedingManaging Member of 10% OwnerBuyindirect+5,668$58.00$329 K2.85 MForm 4
filed Chad BoedingManaging Member of 10% OwnerBuyindirect+417$57.22$24 K2.85 MForm 4
filed David LamondDirectorBuyindirect+400$54.09$22 K1.66 MForm 4
filed David LamondDirectorBuyindirect+5,906$55.42$327 K1.67 MForm 4
filed David LamondDirectorBuyindirect+32,894$56.42$1.9 M1.70 MForm 4
filed David LamondDirectorBuyindirect+1,263$46.30$58 K1.65 MForm 4
filed David LamondDirectorBuyindirect+985$48.37$48 K1.66 MForm 4
filed David LamondDirectorBuyindirect+1,600$48.96$78 K1.66 MForm 4
filed David LamondDirectorBuyindirect+1,000$50.71$51 K1.66 MForm 4
filed David LamondDirectorBuyindirect+500$52.20$26 K1.66 MForm 4
filed David LamondDirectorBuyindirect+100$53.10$5 K1.66 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyindirect · amended+420$24.87$10 K2.85 MForm 4/A
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyamended+1,635$24.87$41 K2.85 MForm 4/A
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuyindirect+420$24.87$10 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuy+1,635$24.87$41 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyindirect · amended+600$25.69$15 K2.84 MForm 4/A
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyamended+2,310$25.69$59 K2.85 MForm 4/A
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuyindirect+600$25.69$15 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuy+2,310$25.69$59 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyindirect · amended+2,100$26.50—2.84 MForm 4/A
filed Chad BoedingManaging Member of IABuyindirect+2,100$26.50$56 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member of 10% owneBuyindirect · amended+700$26.37—2.84 MForm 4/A
filed Chad BoedingManaging Member of IABuyindirect+700$26.37$18 K2.83 MForm 4
filed Una S. RyanDirectorBuyindirect+2,875$17.00$49 K2,875Form 4
filed Kevin YoungDirectorBuy+30,000$17.00$510 K30,000Form 4
filed Margaret McLoughlinDirectorBuy+550$17.00$9 K550Form 4
filed Pfizer Ventures (US) LLC10% ownerBuy+50,000$17.00$850 K3.25 MForm 4
filed Chad BoedingManaging Member of Managing MeBuyamended+4,350$26.41—2.84 MForm 4/A
filed Chad BoedingManaging Member of Managing MeBuyindirect · amended+4,170$27.58—2.84 MForm 4/A
filed Chad BoedingManaging Member of Managing MeBuyindirect · amended+80$27.05—2.84 MForm 4/A
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuy+4,350$26.41$115 K2.82 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuyindirect+4,170$27.58$115 K2.83 MForm 4
filed EPIQ Capital Group, LLCIA/Managing Member 10% ownerBuyindirect+80$27.05$2 K2.83 MForm 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice